CRL 4Q10 4Q Revenues: $282 million (-3%) 4Q Loss: $348 million (earnings of $17 million in 4Q09) FY Revenues: $1.1 billion (-3%) FY Loss: $342 million (earnings of $113 million in FY09) Comments: CRL wrote down $305 million in goodwill writeoffs in 4Q10, as well as a $90 million writeoff for preclinical facilities in China and Massachusetts. The company considers its Phase I business to be a discontinued operation, but we’ve included its results in the overall figures. Reven...